# The NADage Study: Nicotinamide Riboside Replenishment Therapy Against Functional Decline in Aging

> **NCT06208527** · PHASE2 · RECRUITING · sponsor: **Haukeland University Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Frailty
- Frail Elderly Syndrome
- Frailty Syndrome
- Aging

## Interventions

- **DIETARY_SUPPLEMENT:** Nicotinamide Riboside (NR)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06208527
- **Lead sponsor:** Haukeland University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01
- **Primary completion:** 2027-12
- **Final completion:** 2030-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06208527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06208527, "The NADage Study: Nicotinamide Riboside Replenishment Therapy Against Functional Decline in Aging". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06208527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*